Continuous intravenous infusion of dipyridamole as adjunctive therapy in the treatment of thrombotic thrombocytopenic purpura

Transfusion and Apheresis Science

Volumn 29, Issue 2, 2003, Pages 141-145

  Quintini, Gerlando ^a   Barbera, Vincenzo ^a   Iannitto, Emilio ^a   Spadola, Vincenzo ^a   Fadda, Raffaela ^a   Greco, Gioacchino ^a   Mazzola, Giuseppina ^a   Mariani, Guglielmo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Dipyridamole; Therapy; TTP

Indexed keywords

DIPYRIDAMOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; PLASMAPHERESIS; REFRACTORY PERIOD; REMISSION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

EID: 0042163088     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(03)00118-6     Document Type: Article

References (15)

1. Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: an undescribed disease. Arch. Intern. Med. 36:1925;294-310.
2. Rock G., Porta C., Bobbio-Pallavicini E. Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica. 85:2000;410-419.
3. Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.G., Nair R.C.et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N. Engl. J. Med. 325:1991;393-397.
4. Myers T.J., Wakem C.J., Ball E.D., Tremont S.J. Thrombotic thrombocytopenic purpura: combined treatment with plasmpheresis and antiplatelet agents. Ann. Intern. Med. 92:1980;149-155.
5. Musso M., Porretto F., Crescimannoet al. Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34+) cell transplantation. Bone Marrow Trasplant. 24:1999;207-209.
6. Bobbio-Pallavicini E., Porta C., Fornasari P.M., Viarengo G.L., Ascari E. Thrombotic thrombocytopenic purpura (TTP): retrospective study on 84 patients and therapeutical prospects. Transf. Sci. 13:1992;39-44.
7. Kelton J.G. Antiplatelet agents: rationale and results. Clin. Haematol. 12:1983;311-354.
8. Asada Y., Sumiyoshi A., Hayashi T., Suzumiya J., Kaketani K. Immunohistochemistry of vascular lesion in thrombotic thrombocitopenic purpura, with special reference to factor VIII-related antigens. Thromb. Res. 38:1985;649-679.
9. Amorosi E.L., Karpatkin S. Antiplatelet treatment of thrombotic thrombocytopenic purpura. Ann. Intern. Med. 86:1977;102-106.
10. Eckel R.H., Crowell E.B., Waterhouse B.E., Bozdech M.J. Platelet inhibiting drugs in thrombotic thrombocytopenic purpura. Arch. Intern. Med. 137:1977;735-737.
11. Giromini M., Bouvier C.A., Dami R., Denizot M., Jeannet M. Effect of dipyridamole and aspirin in thrombotic microangiopathy. Br. Med. J. 1:1972;545-546.
12. Rossi E.C., Redondo D., Borges W.H. Thrombotic thrombocytopenic purpura. Survival following treatment with aspirin, dipyridamole and prednisone. JAMA. 228:1974;1141-1143.
13. Bobbio-Pallavicini E., Gugliotta L., Centurioni C., Porta C., Vianelli N., Billio A.et al. Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica. 82:1997;429-435.
14. Rosove M.H., Ho W.G., Golfinger D. Ineffectiveness of aspirin and dipyridamole in treatment of thrombotic thrombocytopenic purpura. Ann. Intern. Med. 96:1982;27-33.
15. Bell W.R., Braine H.G., Ness P.M., Kickler T.S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N. Engl. J. Med. 325(6):1991;398-403.